Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

15th International Workshop on Chronic Lymphocytic Leukaemia (iwCLL 2013) /
The future of CLL treatment: balancing efficacy, safety and cost

9th - 11th Sep 2013

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.11.13
Views: 3781

Dr Susan O’Brien - MD Anderson Cancer Center, Houston, Texas, USA

Dr Susan O’Brien from MD Anderson Cancer Center, Houston, Texas, USA, chairs an interesting and stimulating symposium sponsored by Mundipharm International on issues affecting the management of CLL held during the 15th International Workshop on Chronic Lymphocytic Leukaemia – iwCLL – in September 2013. 

With the numerous major advances that have been made in CLL over the past few years come opportunities and challenges for patients and health care professionals.  These opportunities include improved PFS and OS; these challenges include which agents to select and how, which agents to use in combination, how to manage older/frail patients and how to pay for these newer therapies.  All these issues are addressed in this symposium by three international experts and a lively panel discussion that answers questions from the packed audience.


Content taken from a Mundipharma sponsored satellite symposium at iwCLL 2013 as part of the official programme.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation